Patrik Jonsson is executive vice president of Eli Lilly and Company, president of Lilly Cardiometabolic Health, and president of Lilly USA.

Patrik previously served as executive vice president and president of Lilly Immunology, Lilly Bio-Medicines and general manager of Lilly Sweden, Scandinavia, Italy and Japan. Since joining Lilly in 1990 as a sales representative, Patrik has held a number of positions in sales, marketing, and general management. He served as European marketing director for Zyprexa and the neuroscience customer group, as managing director of Sweden and later of Scandinavia (Sweden, Norway and Denmark), and as president and general manager of Eli Lilly Italia, adding responsibilities for countries in central and southeastern Europe in 2012. In 2014, he became president and general manager of Lilly Japan.

Patrik is a business graduate from Lund University School of Economics and Management in Sweden.

He is the past chair of the Japan-based executive committee of PhRMA and served on the board of the American Chamber of Commerce in Japan.